Ülke: ABD
Dil: İngilizce
Kaynak: NLM (National Library of Medicine)
Potassium Phosphate, Monobasic (UNII: 4J9FJ0HL51) (Potassium Cation - UNII:295O53K152, Phosphate Ion - UNII:NK08V8K8HR), Potassium Phosphate, Dibasic (UNII: CI71S98N1Z) (Potassium Cation - UNII:295O53K152, Phosphate Ion - UNII:NK08V8K8HR)
Fresenius Kabi USA, LLC
INTRAVENOUS
PRESCRIPTION DRUG
Potassium Phosphates Injection is indicated as a source of phosphorus: - in intravenous fluids to correct hypophosphatemia in adults and pediatric patients when oral or enteral replacement is not possible, insufficient or contraindicated. - for parenteral nutrition in adults and pediatric patients when oral or enteral nutrition is not possible, insufficient or contraindicated. Potassium Phosphates Injection is contraindicated in patients with: - hyperkalemia [see Warning and Precautions (5.3)] - severe renal impairment (eGFR less than 30 mL/min/1.73m2 ) or end stage renal disease [see Warning and Precautions (5.3)] - hyperphosphatemia [see Warning and Precautions (5.4)] - hypercalcemia or significant hypocalcemia [see Warning and Precautions (5.4)] Risk Summary Administration of the recommended dose of Potassium Phosphates Injection is not expected to cause major birth defects, miscarriage, or adverse maternal or fetal outcomes. Animal reproduction studies have not been conducted with Potassium Phosphates Inj
Potassium Phosphates Injection, USP is a clear and colorless solution supplied as phosphorus 3 mmol/mL and potassium 4.4 mEq/mL as shown: Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Pharmacy Bulk Package vial: Discard within 4 hours of initial entry [see Dosage and Administration (2.3)]. For storage of admixed solution see Dosage and Administration 2.1, 2.3.
New Drug Application
POTASSIUM PHOSPHATES- POTASSIUM PHOSPHATE, MONOBASIC POTASSIUM PHOSPHATE, DIBASIC INJECTION, SOLUTION, CONCENTRATE FRESENIUS KABI USA, LLC ---------- HIGHLIGHTS OF PRESCRIBING INFORMATION THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE POTASSIUM PHOSPHATES INJECTION SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR POTASSIUM PHOSPHATES INJECTION. POTASSIUM PHOSPHATES INJECTION, FOR INTRAVENOUS USE. INITIAL U.S. APPROVAL: 1983 INDICATIONS AND USAGE Potassium Phosphates Injection is a phosphorus replacement product indicated as a source of phosphorus: in intravenous fluids to correct hypophosphatemia in adults and pediatric patients when oral or enteral replacement is not possible, insufficient or contraindicated. (1) for parenteral nutrition in adults and pediatric patients when oral or enteral nutrition is not possible, insufficient or contraindicated. (1) DOSAGE AND ADMINISTRATION Administer intravenously only after dilution or admixing in a larger volume of fluid. (2.1) Potassium Phosphates Injection provides phosphorus 3 mmol/mL (potassium 4.4 mEq/mL). (2.2, 2.4) Monitor serum phosphorus, potassium, calcium, and magnesium concentrations. (2.2, 2.4) See full prescribing information for instructions on preparation and administration. (2.1, 2.3) Recommended Dosage for Correction of Hypophosphatemia in Intravenous Fluids POTASSIUM PHOSPHATES INJECTION is only for administration to a patient with a serum potassium concentration less than 4 mEq/dL; otherwise, use an alternative source of phosphorus. (2.1) The dosage is dependent upon the individual needs of the patient, and the contribution of phosphorus and potassium from other sources. (2.2) See full prescribing information for recommendations on initial or single dosing, repeated dosing, concentration and infusion rate. (2.1, 2.2) Recommended Dosage for Administration in Parenteral Nutrition Individualize the dosage based upon the patient's clinical condition, nutritional requirements, and the contribution of oral or enteral phosphoru Belgenin tamamını okuyun